Oncologic PET-CT: The importance of a multidisciplinary team;PET-TC en oncología: La importancia de un equipo multidisciplinar

Radiologia

Volumn 51, Issue 1, 2009, Pages 6-14

  Maldonado, A ^a  

^a HOSPITAL RUBER INTERNACIONAL   (Spain)

Author keywords

Cone beam computed tomography; Diagnostic imaging; Medical oncology; PET CT; Positron emission tomography; Radiation oncology

Indexed keywords

6 FLUORODOPA F 18; CHOLINE C 11; FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18; METHIONINE C 11; RADIOPHARMACEUTICAL AGENT;

CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; FOLLOW UP; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIATION PROTECTION; RADIODIAGNOSIS; RADIOLOGIST; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION;

EID: 62449096953     PISSN: 00338338     EISSN: 15781771     Source Type: Journal    
DOI: 10.1016/S0033-8338(09)70400-X     Document Type: Article

References (23)

1. Larson SM. Practice-based evidence of the beneficial impact of positron emission tomography in clinical oncology. J Clin Oncol. 2008;26:2083-4.
2. Pichler BJ, Wehrl HF, Kolb A, Judenhofer MS. Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging? Semin Nucl Med. 2008;38:199-208.
3. Lecchi M, Fossati P, Elisei F, Orecchia R, Lucignani G. Current concepts on imaging in radiotherapy. Eur J Nucl Med Mol Imaging. 2007;35:821-37.
4. Chang JY, Dong L, Liu H, Starkschall G, Balter P, Mohan R, et al. Image-guided radiation therapy for non-small cell lung cancer. J Thorac Oncol. 2008;3:177-86.
5. Cortés-Blanco A. Especificaciones actuales de la ficha técnica de los radiofármacos compuestos de fluorodesoxiglucosa (18F) autorizados para comercialización en España. Seguri-dad Nuclear. 2006;40:218.
6. Kennedy JA, Israel O, Frenkel A, Bar-Shalom R, Azhari H. Improved image fusion in PET/CT using hybrid image reconstruction and super-resolution. Int J Biomed Imaging. 2007;2007:46846.
7. Du H, Yang Y, Cherry SR. Comparison of four depth-encoding PET detector modules with wavelength shifting (WLS) and optical fiber read-out. Phys Med Biol. 2008;53:1829-42.
8. Miles KA, Williams RE. Warburg revisited: imaging tumour blood flow and metabolism. Cancer Imaging. 2008;8:81-6.
9. Ametamey SM, Honer M, Schubiger PA. Molecular imaging with PET. Chem Rev. 2008;108:1501-16.
10. Juergens KU, Oei ML, Weckesser M, Franzius C, Wormanns D, Schober O, et al. Whole-body imaging of oncologic patients using 16-channel PET-CT. Evaluation of an i.v. contrast enhanced MDCT protocol. Nuklearmedizin. 2008;47:30-6.
11. Nehmeh SA, Erdi YE. Respiratory motion in positron emission tomography/computed tomography: a review. Semin Nucl Med. 2008;38:167-76.
12. Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med. 2003;44:1200-9.
13. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003;348:2500-7.
14. Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology. 2003;229:526-33.
15. Keidar Z, Haim N, Guralnik L, Wollner M, Bar-Shalom R, Ben-Nun A, et al. PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. J Nucl Med. 2004;45:1640-6.
16. Cohade C, Osman M, Leal J, Wahl RL. Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med. 2003;44:1797-803.
17. Israel O, Mor M, Guralnik L, Hermoni N, Gaitini D, Bar-Shalom R, et al. Is 18F-FDG PET/CT useful for imaging and management of patients with suspected occult recurrence of cancer? J Nucl Med. 2004;45:2045-51.
18. Even-Sapir E, Parag Y, Lerman H, Gutman M, Levine C, Rabau M, et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology. 2004;232:815-22.
19. Freudenberg LS, Antoch G, Schutt P, Beyer T, Jentzen W, Muller SP, et al. FDG-PET/CT in re-staging of patients with lymphoma. Eur J Nucl Med Mol Imaging. 2004;31:325-9.
20. Gutzeit A, Antoch G, Kuhl H, Egelhof T, Fischer M, Hauth E, et al. Unknown primary tumors: detection with dual-modality PET/CT-initial experience. Radiology. 2005;234:227-34.
21. Hillner BE, Siegel BA, Liu D, Shields AF, Gareen IF, Hanna L, et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol. 2008;26:2155-61.
22. Calvo FA. PET-TAC en oncología: una extraordinaria oportu-nidad asistencial, docente e investigadora. Rev Esp Med Nucl. 2007;26:67-8.
23. Stegger L, Schafers M, Weckesser M, Schober O. EANM-ESR white paper on multimodality imaging. Eur J Nucl Med Mol Imaging. 2008;35:677-80.